CAD 0.9
(7.14%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 19.44 Million USD | 1.49% |
2022 | 19.15 Million USD | -7.29% |
2021 | 20.66 Million USD | 25.59% |
2020 | 16.45 Million USD | 12680.56% |
2019 | 128.72 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 5.18 Million USD | -60.32% |
2024 Q1 | 13.06 Million USD | -32.81% |
2023 Q2 | 16.3 Million USD | -15.19% |
2023 FY | 19.44 Million USD | 1.49% |
2023 Q4 | 19.44 Million USD | 61.14% |
2023 Q1 | 19.22 Million USD | 0.38% |
2023 Q3 | 12.06 Million USD | -26.02% |
2022 Q4 | 19.15 Million USD | 14.31% |
2022 FY | 19.15 Million USD | -7.29% |
2022 Q3 | 16.75 Million USD | -9.93% |
2022 Q2 | 18.6 Million USD | -0.87% |
2022 Q1 | 18.76 Million USD | -9.17% |
2021 Q4 | 20.66 Million USD | 5.16% |
2021 FY | 20.66 Million USD | 25.59% |
2021 Q2 | 19.78 Million USD | 2.16% |
2021 Q1 | 19.36 Million USD | 17.73% |
2021 Q3 | 19.64 Million USD | -0.7% |
2020 Q3 | 207.29 Thousand USD | 0.0% |
2020 Q4 | 16.45 Million USD | 7836.69% |
2020 FY | 16.45 Million USD | 12680.56% |
2019 Q4 | 128.72 Thousand USD | 0.0% |
2019 FY | 128.72 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 5.06 Million CAD | -283.919% |
CanadaBis Capital Inc. | 7.3 Million CAD | -165.973% |
Decibel Cannabis Company Inc. | 40.96 Million CAD | 52.542% |
Delivra Health Brands Inc. | 2.02 Million CAD | -859.091% |
Entourage Health Corp. | 161.58 Million CAD | 87.968% |
Lifeist Wellness Inc. | 1.26 Million CAD | -1435.587% |
Cannara Biotech Inc. | 45.78 Million CAD | 57.537% |
Medicure Inc. | 544 Thousand CAD | -3473.673% |
PharmaCielo Ltd. | 18.3 Million CAD | -6.183% |
Rubicon Organics Inc. | 10.25 Million CAD | -89.489% |
BioSyent Inc. | 1.22 Million CAD | -1492.143% |
Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -48501.955% |